Adial 
Welcome,         Profile    Billing    Logout  
 1 Product   0 Diseases  1 Product   1 Trial   45 News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ondansetron ultra-low dose (AD04) / Adial
2022-003532-73: A Phase 2b, Multicenter, Randomized, Placebo-controlled, Double-blind Study to Assess the Safety and Efficacy of AD04 in Patients with Early Alzheimer’s Disease - ADVANCE Multicentrické, randomizované, placebom-kontrolované, dvojito zaslepené klinické skúšanie fázy 2b na stanovenie bezpečnosti a účinnosti produktu AD04 u pacientov s včasnou Alzheimerovou chorobou – ADVANCE

Not yet recruiting
2
122
Europe, RoW
AD04, AD04, Solution for injection
ADvantage Therapeutics GmbH, ADvantage Therapeutics GmbH
early Alzheimer’s disease, early Alzheimer’s disease, Diseases [C] - Nervous System Diseases [C10]
 
 
PNV2 / Adial
No trials found
PNV-6005 / Adovate
No trials found
PNV-5030 / Adial
No trials found
PNV-5032 / Adial
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ondansetron ultra-low dose (AD04) / Adial
2022-003532-73: A Phase 2b, Multicenter, Randomized, Placebo-controlled, Double-blind Study to Assess the Safety and Efficacy of AD04 in Patients with Early Alzheimer’s Disease - ADVANCE Multicentrické, randomizované, placebom-kontrolované, dvojito zaslepené klinické skúšanie fázy 2b na stanovenie bezpečnosti a účinnosti produktu AD04 u pacientov s včasnou Alzheimerovou chorobou – ADVANCE

Not yet recruiting
2
122
Europe, RoW
AD04, AD04, Solution for injection
ADvantage Therapeutics GmbH, ADvantage Therapeutics GmbH
early Alzheimer’s disease, early Alzheimer’s disease, Diseases [C] - Nervous System Diseases [C10]
 
 
PNV2 / Adial
No trials found
PNV-6005 / Adovate
No trials found
PNV-5030 / Adial
No trials found
PNV-5032 / Adial
No trials found

Download Options